EBV gene expression in an NPC-related tumour
- PMID: 2479554
- PMCID: PMC401270
- DOI: 10.1002/j.1460-2075.1989.tb08404.x
EBV gene expression in an NPC-related tumour
Abstract
A nasopharyngeal carcinoma tumour (designated C15) propagated in nude mice has been used to generate a large cDNA library that we have analysed for Epstein-Barr virus (EBV) gene expression. No gross alterations exist in viral DNA from C15 relative to other human isolates and the large deletion present in the B95-8 'prototype' viral strain established in marmoset cells is not found; C15 contains no linear virion DNA. In the cDNA library, of the six EBV nuclear antigens (EBNAs) expressed in latently infected B-lymphocytes, only clones for EBNA-1 are found. These data are confirmed by immunoblotting. Sequence analysis shows the EBNA-1 mRNA splicing pattern in the carcinoma to differ from that observed in B-lymphocytes. Further, contrary to observations with B-cell lines, most viral transcription in the tumour is localized onto the 'rightmost' region of the conventional EBV physical map. Transcripts identified corresponding to known genes include those for the latent membrane protein (LMP), the alkaline DNA exonuclease and probably the terminal protein; major transcripts are also derived from the BamHI D fragment and the region deleted in B95-8 EBV DNA. Novel transcripts have also been identified that proceed in an anti-sense direction to genes encoding functions associated with replication, such as the viral DNA polymerase. They contain a large, hitherto unidentified, open reading frame in the viral genome that is complementary to the putative function known as BALF3 and a smaller open reading frame complementary to BALF5 (the DNA polymerase gene). From the present studies we can conclude that: (i) EBV transcription patterns in the epithelial cells vary markedly from those identified previously in B-cells, reflecting differential use of promoters or splicing patterns. (ii) Transcription is tightly regulated and restricted in the C15 tumour with many latent genes, notably EBNAs 2-6, being 'switched off.' (iii) A family of cytoplasmic RNAs are transcribed in an antisense direction to a number of existing open reading frames in the EBV genome. (iv) There are a number of mutations in C15 transcripts relative to the B95-8 genome, some of which could result in amino acid alterations in proteins.
Similar articles
-
Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma.J Virol. 1990 Oct;64(10):4948-56. doi: 10.1128/JVI.64.10.4948-4956.1990. J Virol. 1990. PMID: 2168978 Free PMC article.
-
Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells.J Virol. 1992 Feb;66(2):706-14. doi: 10.1128/JVI.66.2.706-714.1992. J Virol. 1992. PMID: 1370554 Free PMC article.
-
Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.J Virol. 1991 Mar;65(3):1558-67. doi: 10.1128/JVI.65.3.1558-1567.1991. J Virol. 1991. PMID: 1847471 Free PMC article.
-
Immortalizing genes of Epstein-Barr virus.Adv Virus Res. 1991;40:19-55. doi: 10.1016/s0065-3527(08)60276-6. Adv Virus Res. 1991. PMID: 1659776 Review.
-
The role of miRNAs and EBV BARTs in NPC.Semin Cancer Biol. 2012 Apr;22(2):166-72. doi: 10.1016/j.semcancer.2011.12.001. Epub 2011 Dec 10. Semin Cancer Biol. 2012. PMID: 22178394 Free PMC article. Review.
Cited by
-
Validation of a Highly Sensitive qPCR Assay for the Detection of Plasma Cell-Free Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma Diagnosis.Cancer Control. 2020 Jul-Aug;27(3):1073274820944286. doi: 10.1177/1073274820944286. Cancer Control. 2020. PMID: 32726136 Free PMC article.
-
The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.J Virol. 1992 Dec;66(12):7461-8. doi: 10.1128/JVI.66.12.7461-7468.1992. J Virol. 1992. PMID: 1331531 Free PMC article.
-
Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.J Virol. 1996 Jan;70(1):623-7. doi: 10.1128/JVI.70.1.623-627.1996. J Virol. 1996. PMID: 8523583 Free PMC article.
-
Molecular basis for Epstein-Barr virus induced pathogenesis and disease.Springer Semin Immunopathol. 1991;13(2):133-46. doi: 10.1007/BF00201464. Springer Semin Immunopathol. 1991. PMID: 1664982 Review. No abstract available.
-
Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma.J Virol. 1990 Oct;64(10):4948-56. doi: 10.1128/JVI.64.10.4948-4956.1990. J Virol. 1990. PMID: 2168978 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources